Bruschi Giuseppe, De Marco Federico, Oreglia Jacopo, Colombo Paola, Fratto Pasquale, Lullo Francesca, Paino Roberto, Frigerio Maria, Martinelli Luigi, Klugmann Silvio
A De Gasperis Cardiology and Cardiac Surgery Department, Niguarda Ca' Granda Hospital, Milan, Italy.
Ann Thorac Surg. 2009 Nov;88(5):e50-2. doi: 10.1016/j.athoracsur.2009.07.028.
Concerns exist in the field of transcatheter aortic valve implantation regarding the treatment of patients with mechanical mitral valve for possible interference between the percutaneous aortic valve and the mechanical mitral prosthesis. We report our experience with percutaneous aortic valve implantation in 4 patients with severe aortic stenosis, previously operated on for mitral valve replacement with a mechanical prosthesis. All patients underwent uneventful percutaneous retrograde CoreValve implantation (CoreValve Inc, Irvine, CA). No deformation of the nitinol tubing of the prostheses (ie, neither distortion nor malfunction of the mechanical valve in the mitral position) occurred in any of the patients. All patients are alive and asymptomatic at a mean follow-up of 171 days.
在经导管主动脉瓣植入领域,对于接受机械二尖瓣置换术的患者,由于经皮主动脉瓣与机械二尖瓣假体之间可能存在干扰,因此存在一些担忧。我们报告了4例严重主动脉瓣狭窄患者经皮主动脉瓣植入的经验,这些患者此前均接受过机械瓣膜二尖瓣置换术。所有患者均顺利接受了经皮逆行CoreValve植入术(CoreValve公司,加利福尼亚州欧文市)。所有患者均未出现假体镍钛诺管变形(即二尖瓣位置的机械瓣膜未出现扭曲或故障)。所有患者在平均171天的随访期内均存活且无症状。